News
You are here: Home » News

Knowledge Center

Synthetic Peptide Drug Development Platform

These articles are all highly relevant Synthetic Peptide Drug Development Platform. I believe this information can help you understand Synthetic Peptide Drug Development Platform's professional information. If you want to know more, you can contact us at any time, we can provide you with more professional guidance.
  • 2025-06-09

    In recent years, peptide-based therapeutics have taken center stage in drug development, combining the best of small molecules and biologics: high target specificity, potent activity, and favorable safety profiles. But formulating a high-quality peptide drug substance (PDS) isn't simply a matter of sequence—it relies on intelligent peptide discovery strategies that integrate stability, manufacturability, and functionality from the very start. Beginning optimization at the discovery phase significantly elevates the likelihood of downstream success.
  • 2025-06-09

    Peptides have rapidly emerged as a vital class of therapeutics, offering unique advantages such as high specificity, potency, and safety profiles. The journey from peptide discovery to a viable peptide drug substance is complex, involving multidisciplinary efforts that bridge early-stage research and clinical application.
  • 2025-06-09

    Peptides have emerged as a powerful class of therapeutic agents due to their high specificity, potency, and generally favorable safety profiles. As drug discovery continues to evolve, peptide discovery​has gained significant traction in both academic research and pharmaceutical development. However, unlocking the full therapeutic potential of peptides requires innovative strategies that overcome inherent challenges such as stability, delivery, and target specificity.
  • 2025-04-14

    In recent years, the development of peptide-based drugs has witnessed remarkable progress, especially with the success of modified peptides like Semaglutide and Tirzepatide.
  • 2025-04-14

    In recent years, peptide-based therapeutics have taken center stage in the pharmaceutical industry. Their high specificity, low toxicity, and proven clinical effectiveness have made peptides an essential component in the development of treatments for metabolic disorders, cancer, infectious diseases, and beyond.
  • Total 2 pages  Go to Page
  • Go
 +86-513-55880580

About Us

Products & Services

Investor Relations

News

Leave a Message
Contact Us
Copyright © 2024 Xiushi-Peptide All Rights Reserved. Sitemap Privacy Policy Supported By leadong.com  苏ICP备2023048630号-1